diucifon has been researched along with Convalescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ermakov, EV; Gorlina, NK; Kolomoets, NM; Leskov, VP; Novozhenov, VT | 1 |
| Karaulov, AV; Khromenkov, IuI; Khvatalin, IV; Martsinovskiĭ, VIu; Plakhov, IV | 1 |
1 trial(s) available for diucifon and Convalescence
| Article | Year |
|---|---|
[Therapeutic effectiveness of diucifon in acute pneumonia based on clinico-immunological and bronchoscopic study data].
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Antibody Formation; Bronchoscopy; Clinical Trials as Topic; Convalescence; Drug Combinations; Female; Humans; Immunity, Cellular; Male; Middle Aged; Pneumonia; Sulfones; Uracil | 1983 |
1 other study(ies) available for diucifon and Convalescence
| Article | Year |
|---|---|
[Various aspects of immunomodulating therapy in patients with protracted pneumonia during convalescence].
Topics: Adjuvants, Immunologic; Adolescent; Adult; B-Lymphocytes; Benzhydryl Compounds; Convalescence; Drug Combinations; Drug Therapy, Combination; Estrenes; Follow-Up Studies; Humans; Leukocyte Count; Lymphopenia; Middle Aged; Pneumonia; Polysaccharides, Bacterial; Prodigiozan; Sulfones; T-Lymphocytes; Time Factors; Trace Elements; Uracil | 1986 |